MedPath
HSA Approval

IOMERON 350 INJECTION 350 mg/ml

SIN08462P

IOMERON 350 INJECTION 350 mg/ml

IOMERON 350 INJECTION 350 mg/ml

November 30, 1995

DCH AURIGA SINGAPORE

DCH AURIGA SINGAPORE

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDCH AURIGA SINGAPORE
Licence HolderDCH AURIGA SINGAPORE

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

![Iomeron Dosage Table 1](https://cdn.medpath.com/drug/dosage/20240520/e2dd3b788ac9f3f29f787b17f22e7fef.png)

INTRAVASCULAR

Medical Information

**Indications** Iomeron 300Intravenous urography (in adults and paediatrics), peripheral phlebography, CT (brain and body), cavernosography, intravenous DSA, conventional angiography, intraarterial DSA, angiocardiography (in adults and paediatrics), conventional selective coronary arteriography, interventional coronary arteriography, ERCP, arthrography, hysterosalpingography, fistulography, discography, galactography, cholangiography, dacryocystography, sialography, retrograde urethrography, retrograde pyelo-ureterography.Iomeron 350Intravenous urography (in adults and paediatrics), CT (body), intravenous DSA, conventional angiography, intraarterial DSA, angiocardiography (in adults and paediatrics), conventional selective coronary arteriography, interventional coronarography, arthrography, hysterosalpingography, fistulography, galactography, cholangiography, dacryocystography, sialography.Iomeron 400Intravenous urography, (in adults including those with renal impairment or diabetes), CT (body), conventional angiography, intraarterial DSA, angiocardiography (in adults and paediatrics), conventional selective coronary arteriography, interventional coronary arteriography, fistulography, galactography, dacryocystography, sialography. CT: Computed Tomography DSA: Digital Subtraction Angiography ERCP: Endoscopic Retrograde Cholangio-Pancreatography

**Contraindications** Iomeprol Injection should not be administered to patients with known hypersensitivity to iomeprol or any of the excipients. Investigations of the female genitalia are contraindicated in suspected or confirmed pregnancy and in cases of acute inflammation.

V08AB10

iomeprol

Manufacturer Information

DCH AURIGA SINGAPORE

Patheon Italia S.p.A

Active Ingredients

IOMEPROL EQV IODINE

350 mg/ml

Iomeprol

Documents

Package Inserts

Iomeron Injection PI.pdf

Approved: June 8, 2023

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

IOMERON 350 INJECTION 350 mg/ml - HSA Approval | MedPath